JP2010142235A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010142235A5 JP2010142235A5 JP2010000087A JP2010000087A JP2010142235A5 JP 2010142235 A5 JP2010142235 A5 JP 2010142235A5 JP 2010000087 A JP2010000087 A JP 2010000087A JP 2010000087 A JP2010000087 A JP 2010000087A JP 2010142235 A5 JP2010142235 A5 JP 2010142235A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- seq
- amino acid
- htdag8
- acid position
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 22
- 150000001413 amino acids Chemical class 0.000 claims 16
- 235000001014 amino acid Nutrition 0.000 claims 13
- 101000738506 Homo sapiens Psychosine receptor Proteins 0.000 claims 12
- 102100037860 Psychosine receptor Human genes 0.000 claims 11
- 238000006467 substitution reaction Methods 0.000 claims 9
- 230000001419 dependent effect Effects 0.000 claims 6
- 229960000310 isoleucine Drugs 0.000 claims 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 6
- 239000003446 ligand Substances 0.000 claims 6
- 102000005962 receptors Human genes 0.000 claims 5
- 108020003175 receptors Proteins 0.000 claims 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 4
- 239000004472 Lysine Substances 0.000 claims 4
- 229940024606 amino acid Drugs 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- 150000002519 isoleucine derivatives Chemical class 0.000 claims 3
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 229960001230 asparagine Drugs 0.000 claims 2
- 235000009582 asparagine Nutrition 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 125000001500 prolyl group Chemical class [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108700008625 Reporter Genes Proteins 0.000 claims 1
- 108091027981 Response element Proteins 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 102000048033 human GPR65 Human genes 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000000018 receptor agonist Substances 0.000 claims 1
- 229940044601 receptor agonist Drugs 0.000 claims 1
Applications Claiming Priority (32)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/170,496 US6555339B1 (en) | 1997-04-14 | 1998-10-13 | Non-endogenous, constitutively activated human protein-coupled receptors |
| US10802998P | 1998-11-12 | 1998-11-12 | |
| US10921398P | 1998-11-20 | 1998-11-20 | |
| US11006098P | 1998-11-27 | 1998-11-27 | |
| US12041699P | 1999-02-16 | 1999-02-16 | |
| US12185299P | 1999-02-26 | 1999-02-26 | |
| US12395199P | 1999-03-12 | 1999-03-12 | |
| US12394999P | 1999-03-12 | 1999-03-12 | |
| US12394499P | 1999-03-12 | 1999-03-12 | |
| US12394599P | 1999-03-12 | 1999-03-12 | |
| US12394899P | 1999-03-12 | 1999-03-12 | |
| US12394699P | 1999-03-12 | 1999-03-12 | |
| US13643799P | 1999-05-28 | 1999-05-28 | |
| US13756799P | 1999-05-28 | 1999-05-28 | |
| US13643999P | 1999-05-28 | 1999-05-28 | |
| US13713199P | 1999-05-28 | 1999-05-28 | |
| US13643699P | 1999-05-28 | 1999-05-28 | |
| US13712799P | 1999-05-28 | 1999-05-28 | |
| US14144899A | 1999-06-30 | 1999-06-30 | |
| US15111499P | 1999-08-27 | 1999-08-27 | |
| US15252499P | 1999-09-03 | 1999-09-03 | |
| US15665399A | 1999-09-09 | 1999-09-09 | |
| US15663499P | 1999-09-29 | 1999-09-29 | |
| US15655599P | 1999-09-29 | 1999-09-29 | |
| US15663399P | 1999-09-29 | 1999-09-29 | |
| US15729399P | 1999-10-01 | 1999-10-01 | |
| US15728199P | 1999-10-01 | 1999-10-01 | |
| US15728299P | 1999-10-01 | 1999-10-01 | |
| US15728099P | 1999-10-01 | 1999-10-01 | |
| US15729499P | 1999-10-01 | 1999-10-01 | |
| US41676099A | 1999-10-12 | 1999-10-12 | |
| US41704499A | 1999-10-12 | 1999-10-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000576021A Division JP2003525018A (ja) | 1998-10-13 | 1999-10-13 | 非内在性の構成的に活性化されるヒトｇタンパク質共役型受容体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010161113A Division JP2010263909A (ja) | 1998-10-13 | 2010-07-15 | 非内在性の構成的に活性化されるヒトｇタンパク質共役型受容体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010142235A JP2010142235A (ja) | 2010-07-01 |
| JP2010142235A5 true JP2010142235A5 (enExample) | 2011-05-19 |
Family
ID=42563313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010000087A Withdrawn JP2010142235A (ja) | 1998-10-13 | 2010-01-04 | 非内在性の構成的に活性化されるヒトｇタンパク質共役型受容体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2010142235A (enExample) |
-
2010
- 2010-01-04 JP JP2010000087A patent/JP2010142235A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cackett et al. | The African swine fever virus transcriptome | |
| Cackett et al. | African swine fever virus and host response: transcriptome profiling of the Georgia 2007/1 strain and porcine macrophages | |
| La Rosa et al. | MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 | |
| Schneider et al. | The nuclear pore-associated TREX-2 complex employs mediator to regulate gene expression | |
| Yip et al. | Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus | |
| JP2010220614A5 (enExample) | ||
| JP2014534207A5 (enExample) | ||
| Generous et al. | Identification of putative interactions between swine and human influenza A virus nucleoprotein and human host proteins | |
| JP2009240328A5 (enExample) | ||
| JP2010115195A5 (enExample) | ||
| WO2012075506A3 (en) | Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses | |
| JP2018505139A5 (enExample) | ||
| JP2010207229A5 (enExample) | ||
| Hayashi et al. | Identification of influenza A virus PB2 residues involved in enhanced polymerase activity and virus growth in mammalian cells at low temperatures | |
| JP2009254375A5 (enExample) | ||
| JP2011050389A5 (enExample) | ||
| JP2013078329A5 (enExample) | ||
| JP2010521655A5 (enExample) | ||
| WO2008085564A3 (en) | Compositions and methods involving truncated recombinant seven g-protein coupled receptors | |
| Yen et al. | The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets | |
| GB0905410D0 (en) | Genotoxicity testing | |
| JP2017502253A5 (enExample) | ||
| JP2017521086A5 (enExample) | ||
| Chen et al. | N-terminal phosphorylation of phosphoprotein of vesicular stomatitis virus is required for preventing nucleoprotein from binding to cellular RNAs and for functional template formation | |
| Kraidlova et al. | The Candida albicans GAP gene family encodes permeases involved in general and specific amino acid uptake and sensing |